Please excuse my ignorance, but if we have a collaboration with one drug maker ie Phizer which goes through a trial study and finds that it's safe and effective, is IMU able to then able to partner it with a similar drug from Merk or does it also have to go through a similar trial study? I presume once it's safe with one it will be safe for all which would then allow IMU to dish it out to everyone? Is this correct?
Thanks in advance.
BD
Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA, page-102
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
